News about Biotechnology

The AI-designed protective betacoronavirus vaccine to be developed jointly by CEPI and Japan?s NEC Group

The AI-designed protective betacoronavirus vaccine to be developed jointly by CEPI and Japan?s NEC Group

CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.

Biotechnology | 09/04/2022 | By Sudeep Soparkar 412

Collaboration between ICMR and Pharma companies to develop Dengue vaccine

Collaboration between ICMR and Pharma companies to develop Dengue vaccine

With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II

Biotechnology | 07/03/2022 | By Darshana 631

Orphan Drug Designation offered by US FDA to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio

Orphan Drug Designation offered by US FDA to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio

The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy

Biotechnology | 17/02/2022 | By Darshana 812

Proteon Pharma to develop bacteriophages as a sustainable alternative to antibiotics in poultry industry

Proteon Pharma to develop bacteriophages as a sustainable alternative to antibiotics in poultry industry

Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry

Biotechnology | 18/10/2021 | By Darshana 742

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade

Biotechnology | 01/09/2021 | By Darshana 465

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad

Biotechnology | 27/08/2021 | By Darshana 453

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.

Biotechnology | 10/08/2021 | By Darshana 440

Pharmexcil seeks list of products requiring SION norms fixation from exporters

Pharmexcil seeks list of products requiring SION norms fixation from exporters

The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner

Biotechnology | 02/08/2021 | By Darshana 460

Ascentage, Innovent Biologics ink pact to commercialize olverembatinib in China and joint clinical development of lisaftoclax

Ascentage, Innovent Biologics ink pact to commercialize olverembatinib in China and joint clinical development of lisaftoclax

Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of HQP1351(olverembatinib), a third-generation BCR-ABL inhibitor and a core drug candidate of Ascentage Pharma

Biotechnology | 16/07/2021 | By Darshana 634

Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC

Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC

Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets

Biotechnology | 15/07/2021 | By Darshana 647

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members